Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literature

Endometrial cancer (EC) is the most common gynecologic cancer in the United States. A majority of new cases are diagnosed as low-grade International Federation of Gynecology and Obstetrics (FIGO) Stage I, with a recurrence risk cited as less than 9 % in the first 2–3 years post-treatment. In this ca...

Full description

Bibliographic Details
Main Authors: Annalyn M. Welp, Linda R. Duska
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Gynecologic Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578924000158
_version_ 1797301435979792384
author Annalyn M. Welp
Linda R. Duska
author_facet Annalyn M. Welp
Linda R. Duska
author_sort Annalyn M. Welp
collection DOAJ
description Endometrial cancer (EC) is the most common gynecologic cancer in the United States. A majority of new cases are diagnosed as low-grade International Federation of Gynecology and Obstetrics (FIGO) Stage I, with a recurrence risk cited as less than 9 % in the first 2–3 years post-treatment. In this case series, we present three unique cases of patients with FIGO 2009 Stage I EC who all went on to present with pelvic colonic recurrences years after their initial treatment, two of the patients outside of the 5-year standard surveillance period. These presentations are described in the context of the available literature on EC colonic recurrence.A review of the literature suggests a previously cited association between endometriosis and unusual recurrence locations may not be as important of a risk factor as previously considered, as most of the cases in the series had no clinical or pathologic history of endometriosis. In addition, most of the included cases did not report a history of endometriosis and 60% of the cohort had received postoperative adjuvant radiation and still went on to experience locoregional recurrence. Further study on the associations between endometriosis, MMR status and EC recurrence, particularly for uncommon anatomic recurrence sites, are warranted to ensure appropriate and timely treatment.
first_indexed 2024-03-07T23:21:33Z
format Article
id doaj.art-17965da851cb4e8b9a80f46e801710fc
institution Directory Open Access Journal
issn 2352-5789
language English
last_indexed 2024-03-07T23:21:33Z
publishDate 2024-02-01
publisher Elsevier
record_format Article
series Gynecologic Oncology Reports
spelling doaj.art-17965da851cb4e8b9a80f46e801710fc2024-02-21T05:28:52ZengElsevierGynecologic Oncology Reports2352-57892024-02-0151101336Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literatureAnnalyn M. Welp0Linda R. Duska1Corresponding author at: a: Department of Obstetrics and Gynecology, University of Virginia Medical Center, 1215 Lee Street, Charlottesville, VA 22903, United States.; Department of Obstetrics and Gynecology, University of Virginia Medical Center, Charlottesville, VA 22903, United StatesDepartment of Obstetrics and Gynecology, University of Virginia Medical Center, Charlottesville, VA 22903, United StatesEndometrial cancer (EC) is the most common gynecologic cancer in the United States. A majority of new cases are diagnosed as low-grade International Federation of Gynecology and Obstetrics (FIGO) Stage I, with a recurrence risk cited as less than 9 % in the first 2–3 years post-treatment. In this case series, we present three unique cases of patients with FIGO 2009 Stage I EC who all went on to present with pelvic colonic recurrences years after their initial treatment, two of the patients outside of the 5-year standard surveillance period. These presentations are described in the context of the available literature on EC colonic recurrence.A review of the literature suggests a previously cited association between endometriosis and unusual recurrence locations may not be as important of a risk factor as previously considered, as most of the cases in the series had no clinical or pathologic history of endometriosis. In addition, most of the included cases did not report a history of endometriosis and 60% of the cohort had received postoperative adjuvant radiation and still went on to experience locoregional recurrence. Further study on the associations between endometriosis, MMR status and EC recurrence, particularly for uncommon anatomic recurrence sites, are warranted to ensure appropriate and timely treatment.http://www.sciencedirect.com/science/article/pii/S2352578924000158Endometrial cancerRecurrenceSurveillance
spellingShingle Annalyn M. Welp
Linda R. Duska
Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literature
Gynecologic Oncology Reports
Endometrial cancer
Recurrence
Surveillance
title Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literature
title_full Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literature
title_fullStr Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literature
title_full_unstemmed Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literature
title_short Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literature
title_sort large bowel recurrence of endometrial adenocarcinoma years after treatment a single institution case series and review of the literature
topic Endometrial cancer
Recurrence
Surveillance
url http://www.sciencedirect.com/science/article/pii/S2352578924000158
work_keys_str_mv AT annalynmwelp largebowelrecurrenceofendometrialadenocarcinomayearsaftertreatmentasingleinstitutioncaseseriesandreviewoftheliterature
AT lindarduska largebowelrecurrenceofendometrialadenocarcinomayearsaftertreatmentasingleinstitutioncaseseriesandreviewoftheliterature